187 related articles for article (PubMed ID: 10955818)
1. Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents.
Bagatell R; Paine-Murrieta GD; Taylor CW; Pulcini EJ; Akinaga S; Benjamin IJ; Whitesell L
Clin Cancer Res; 2000 Aug; 6(8):3312-8. PubMed ID: 10955818
[TBL] [Abstract][Full Text] [Related]
2. A trans-activation domain in yeast heat shock transcription factor is essential for cell cycle progression during stress.
Morano KA; Santoro N; Koch KA; Thiele DJ
Mol Cell Biol; 1999 Jan; 19(1):402-11. PubMed ID: 9858564
[TBL] [Abstract][Full Text] [Related]
3. A heat shock protein 90 inhibitor that modulates the immunophilins and regulates hormone receptors without inducing the heat shock response.
McConnell JR; Alexander LA; McAlpine SR
Bioorg Med Chem Lett; 2014 Jan; 24(2):661-6. PubMed ID: 24360559
[TBL] [Abstract][Full Text] [Related]
4. Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones.
Ochel HJ; Eichhorn K; Gademann G
Cell Stress Chaperones; 2001 Apr; 6(2):105-12. PubMed ID: 11599571
[No Abstract] [Full Text] [Related]
5. Host cell factor requirement for hepatitis C virus enzyme maturation.
Waxman L; Whitney M; Pollok BA; Kuo LC; Darke PL
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13931-5. PubMed ID: 11707594
[TBL] [Abstract][Full Text] [Related]
6. Gambogic acid and gambogenic acid induce a thiol-dependent heat shock response and disrupt the interaction between HSP90 and HSF1 or HSF2.
Pesonen L; Svartsjö S; Bäck V; de Thonel A; Mezger V; Sabéran-Djoneidi D; Roos-Mattjus P
Cell Stress Chaperones; 2021 Sep; 26(5):819-833. PubMed ID: 34331200
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of heat shock protein 90 sensitizes melanoma cells to thermosensitive ferromagnetic particle-mediated hyperthermia with low Curie temperature.
Ito A; Saito H; Mitobe K; Minamiya Y; Takahashi N; Maruyama K; Motoyama S; Katayose Y; Ogawa J
Cancer Sci; 2009 Mar; 100(3):558-64. PubMed ID: 19154416
[TBL] [Abstract][Full Text] [Related]
8. Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease.
Labbadia J; Cunliffe H; Weiss A; Katsyuba E; Sathasivam K; Seredenina T; Woodman B; Moussaoui S; Frentzel S; Luthi-Carter R; Paganetti P; Bates GP
J Clin Invest; 2011 Aug; 121(8):3306-19. PubMed ID: 21785217
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.
Isermann T; Schneider KL; Wegwitz F; De Oliveira T; Conradi LC; Volk V; Feuerhake F; Papke B; Stintzing S; Mundt B; Kühnel F; Moll UM; Schulz-Heddergott R
bioRxiv; 2024 Feb; ():. PubMed ID: 38464125
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of TRAP1 Accelerates the DNA Damage Response, Activation of the Heat Shock Response and Metabolic Reprogramming in Colon Cancer Cells.
Bhasin N; Dabral P; Senavirathna L; Pan S; Chen R
Front Biosci (Landmark Ed); 2023 Sep; 28(9):227. PubMed ID: 37796715
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of a ring-constrained Hsp90 C-terminal inhibitor that exhibits neuroprotective activity.
Zhang Z; You Z; Dobrowsky RT; Blagg BSJ
Bioorg Med Chem Lett; 2018 Sep; 28(16):2701-2704. PubMed ID: 29759728
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Disubstituted Carboranes as Inhibitors of Heat Shock Protein 90-Heat Shock Factor 1 Interaction.
Shao Y; Miura K; Asawa Y; Morita T; Li G; Nakamura H
ACS Med Chem Lett; 2024 May; 15(5):619-625. PubMed ID: 38746882
[TBL] [Abstract][Full Text] [Related]
13. Discovery and optimization of cardenolides inhibiting HSF1 activation in human colon HCT-116 cancer cells.
Nikotina AD; Koludarova L; Komarova EY; Mikhaylova ER; Aksenov ND; Suezov R; Kartzev VG; Margulis BA; Guzhova IV
Oncotarget; 2018 Jun; 9(43):27268-27279. PubMed ID: 29930764
[TBL] [Abstract][Full Text] [Related]
14. Tracking the Activation of Heat Shock Signaling in Cellular Protection and Damage.
Torii S; Rakic P
Cells; 2022 May; 11(9):. PubMed ID: 35563865
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein 90 regulates necroptosis by modulating multiple signaling effectors.
Yang CK; He SD
Cell Death Dis; 2016 Mar; 7(3):e2126. PubMed ID: 26938299
[No Abstract] [Full Text] [Related]
16. Correction to geldanamycin ameliorates multiple organ dysfunction and microthrombosis in septic mice by inhibiting the formation of the neutrophil extracellular network by activating heat shock factor 1 HSF1.
Clin Exp Pharmacol Physiol; 2023 Nov; 50(11):924. PubMed ID: 37652083
[No Abstract] [Full Text] [Related]
17. Heat shock response and autophagy--cooperation and control.
Dokladny K; Myers OB; Moseley PL
Autophagy; 2015; 11(2):200-13. PubMed ID: 25714619
[TBL] [Abstract][Full Text] [Related]
18. Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic flux.
Samarasinghe B; Wales CT; Taylor FR; Jacobs AT
Biochem Pharmacol; 2014 Feb; 87(3):445-55. PubMed ID: 24291777
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic target Hsp90 and cancer hallmarks.
Miyata Y; Nakamoto H; Neckers L
Curr Pharm Des; 2013; 19(3):347-65. PubMed ID: 22920906
[TBL] [Abstract][Full Text] [Related]
20. Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update.
Ciocca DR; Arrigo AP; Calderwood SK
Arch Toxicol; 2013 Jan; 87(1):19-48. PubMed ID: 22885793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
